Loading…
LENZ Therapeutics, Inc. is projected to decline to $5.10 by 2027, a -4% move from its current price of $5.30. LENZ is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/3/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 4 | $5.11 | $5.30 | $5.51 | +0.06% |
| Aug 5 | $5.03 | $5.31 | $5.60 | +0.12% |
| Aug 6 | $4.97 | $5.31 | $5.67 | +0.18% |
| Aug 7 | $4.93 | $5.31 | $5.73 | +0.25% |
| Aug 8 | $4.88 | $5.32 | $5.79 | +0.31% |
| Aug 9 | $4.85 | $5.32 | $5.84 | +0.37% |
| Aug 10 | $4.82 | $5.32 | $5.88 | +0.43% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $4.82 | $5.32 | $5.88 | +0.43% |
| Week 2 | $4.64 | $5.35 | $6.16 | +0.86% |
| Week 3 | $4.51 | $5.37 | $6.39 | +1.30% |
| Week 4 | $4.41 | $5.39 | $6.59 | +1.74% |
| Week 5 | $4.33 | $5.42 | $6.77 | +2.17% |
| Week 6 | $4.26 | $5.44 | $6.95 | +2.61% |
| Week 7 | $4.19 | $5.46 | $7.12 | +3.06% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
LENZ Therapeutics, Inc. operates as a commercial pharmaceutical company that focuses on the development and commercialization of therapies to improve vision in the United States. Its product candidates include VIZZ and LNZ101 for the treatment of presbyopia in adults.
LENZ Therapeutics, Inc. was formerly known as Presbyopia Therapies, Inc. and changed its name to LENZ Therapeutics, Inc. in June 2021. The company was founded in 2013 and is headquartered in Solana Beach, California.
LENZ Therapeutics, Inc. trades at a current price of $5.30 and has a market cap of $166.18M, with an overall market position listed as rank 3877. These figures place the company among smaller-cap healthcare stocks with a focused ophthalmology portfolio.
For 2026, the forecast projects a min of $4.88, an avg of $5.30, and a max of $6.71, with a 0% ROI and neutral sentiment. This provides a narrow 2026 band around the current price and a neutral near-term outlook.
In the longer term, the forecast shows a bullish trajectory beginning in 2029 and continuing through 2050. The 2030 average price is projected at $7.26, with a bullish sentiment and a 37% ROI; 2040 is projected at an average of $9.78 with an 84.6% ROI; and 2050 is projected to average $20.05 with a 278.3% ROI, all labeled as bullish." ,
A major floor 21.3% below — a decisive break under it would weaken the trend.
The nearest floor, 7.9% below — buyers have tended to step in here.
The nearest ceiling, 16.0% above — a clean break opens room to run.
A major ceiling 92.1% above — clearing it would confirm fresh momentum.
Key LENZ support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of LENZ market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $5.67 | Sell | $5.54 | Sell |
| MA 10 | $5.44 | Sell | $5.50 | Sell |
| MA 20 | $5.43 | Sell | $5.55 | Sell |
| MA 50 | $6.17 | Sell | $6.37 | Sell |
| MA 100 | $7.90 | Sell | $8.71 | Sell |
| MA 200 | $14.65 | Sell | $13.62 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 43.51 | Neutral |
| Stoch RSI (14) | 59.68 | Neutral |
| CCI (20) | -26.24 | Neutral |
| Williams %R (14) | -58.00 | Info |
| MACD (12,26,9) | 0.11 | Buy |
| ROC (12) | 6.21 | Buy |
| Bollinger %B (20,2) | 0.41 | Neutral |
| Stochastic %K (14) | 42.00 | Neutral |
| TRIX (15) | -0.68 | Sell |
| Awesome (5,34) | 0.01 | Buy |
| Ultimate (7,14,28) | 49.04 | Neutral |
| Momentum (10) | 0.12 | Buy |
| Aroon Osc (25) | -24.00 | Sell |
| Hull MA (9) | 5.77 | Sell |
| ADX (14) | 20.33 | Sell |
| ATR (14) | 0.23 | Info |
The 30-day technical picture is NEUTRAL. RSI14 is 40, indicating modest momentum, and the short-term moving average alignment shows SMA50 at $6.17 versus SMA200 at $14.65.
The stock’s 30-day range runs from $4.13 to $6.80, framing a relatively compressed near-term trading band. Support is identified at $4.88 and resistance at $6.15, providing a defined path for traders watching near-term price action.
Annualized volatility stands at 70%, signaling substantial but not extreme price swings relative to the price level." ,
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $4.88 | $5.30 | $6.71 | 0% | Neutral | |
| $3.93 | $5.10 | $7.09 | -4% | Neutral | |
| $4.22 | $5.72 | $8.34 | +8% | Neutral | |
| $5.10 | $7.14 | $10.82 | +35% | Bullish | |
| $5.02 | $7.25 | $11.35 | +37% | Bullish | |
| $4.72 | $7.01 | $11.28 | +32% | Bullish | |
| $4.41 | $6.72 | $11.08 | +27% | Bullish | |
| $4.32 | $6.75 | $11.38 | +27% | Bullish | |
| $4.82 | $7.70 | $13.25 | +45% | Bullish | |
| $5.24 | $8.57 | $15.02 | +62% | Bullish | |
| $5.38 | $9.79 | $18.53 | +85% | Bullish | |
| $9.08 | $20.05 | $42.37 | +278% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $4.88 | $5.30 | $6.31 | +0.00% |
| September 2026 | $4.49 | $5.36 | $6.64 | +1.22% |
| October 2026 | $4.64 | $5.61 | $7.04 | +4.49% |
| November 2026 | $4.48 | $5.45 | $6.92 | -2.81% |
| December 2026 | $4.26 | $5.23 | $6.71 | -4.05% |
Click any year to see its month-by-month LENZ forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
LENZ Therapeutics, Inc.'s 2026 outlook centres on $5.30, within a $4.88 to $6.71 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, LENZ could reach as high as $7.09, with a base case around $5.10 and support toward $3.93 — roughly -4% from $5.30. A consolidation phase looks the most probable path here.
Expect LENZ to range from $4.22 to $8.34 through 2028. The $5.72 average target implies a +8% move from current prices. That is up +12% on the projected 2027 average. Price action looks broadly range-bound.
The LENZ price prediction for 2029 points to an average of $7.14 (low $5.10, high $10.82) — a potential gain of +35% on today's $5.30. Buyers look set to stay in control over this stretch.
In 2030, LENZ is projected to trade between $5.02 and $11.35, averaging $7.25 — a potential gain of +37% from today's $5.30. That is up +2% on the projected 2029 average. Momentum favours further upside here.
LENZ Therapeutics, Inc.'s 2031 outlook centres on $7.01, within a $4.72 to $11.28 range. That is -3% versus the projected 2030 average. That marks a +32% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, LENZ could reach as high as $11.08, with a base case around $6.72 and support toward $4.41 — roughly +27% from $5.30. Momentum favours further upside here.
Expect LENZ to range from $4.32 to $11.38 through 2033. The $6.75 average target implies a +27% move from current prices. That is up 0% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The LENZ price prediction for 2034 points to an average of $7.70 (low $4.82, high $13.25) — a potential gain of +45% on today's $5.30. Momentum favours further upside here.
In 2035, LENZ is projected to trade between $5.24 and $15.02, averaging $8.57 — a potential gain of +62% from today's $5.30. That is up +11% on the projected 2034 average. Buyers look set to stay in control over this stretch.
LENZ Therapeutics, Inc.'s 2040 outlook centres on $9.79, within a $5.38 to $18.53 range. That is up +14% on the projected 2035 average. That marks a +85% change versus current levels. Momentum favours further upside here.
By 2050, LENZ could reach as high as $42.37, with a base case around $20.05 and support toward $9.08 — roughly +278% from $5.30. Buyers look set to stay in control over this stretch.
Investing $1,000 in LENZ today (≈ 188.679245 LENZ) could be worth
$3,782.66
+$2,782.66 (+278%) by 2050 · US Dollar
Based on the average projected LENZ price of $20.05 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in LENZwould be worth at today's price.
$1,000 invested in LENZ on Jul 31, 2025 (≈ 33.590863 LENZ) would be worth
$178.03
-$821.97 (-82.2%) today · 0.18× · US Dollar
Based on a LENZ entry price of $29.77 vs. today's $5.3.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $5.48 | $967.15 | -3.3% |
| 1 month ago | $5.79 | $915.37 | -8.5% |
| 3 months ago | $8.88 | $596.85 | -40.3% |
| 6 months ago | $16.3 | $325.15 | -67.5% |
| 1 year ago | $29.77 | $178.03 | -82.2% |
| All time (5.0y) ago | $145.88 | $36.33 | -96.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our LENZ forecast.
Our base-case forecast reaches $11.00 around 2050.
Implied market cap at $11.00: $344.9M
The multi-year forecast paints a bullish path from 2029 onward, with increasingly higher averages and strong returns. In 2029, the min price is $5.10, the avg is $7.14, the max is $10.84, and the ROI is 34.8% with bullish sentiment.
By 2030, the min is $5.03, the avg is $7.26, and the max is $11.36, with a 37% ROI and bullish sentiment. In 2031, the min is $4.71, the avg is $6.99, and the max is $11.25, with a 31.9% ROI and bullish sentiment. In 2032, the min is $4.41, the avg is $6.73, and the max is $11.09, with a 26.9% ROI and bullish sentiment.
In 2033, the min is $4.33, the avg is $6.76, and the max is $11.39, with a 27.5% ROI and bullish sentiment. In 2034, the min is $4.81, the avg is $7.69, and the max is $13.23, with a 45.1% ROI and bullish sentiment. In 2035, the min is $5.24, the avg is $8.58, and the max is $15.04, with a 61.9% ROI and bullish sentiment.
Looking further out, 2040 shows a min of $5.37, an avg of $9.78, a max of $18.52, with an 84.6% ROI and bullish sentiment, and 2050 projects a min of $9.08, an avg of $20.05, a max of $42.38, with a 278.3% ROI and bullish sentiment. These figures illustrate a steadily rising longer-term trajectory, albeit with year-to-year variability.
As a note of caution, some earlier years in the forecast show neutral or negative results (for example 2027 with a -3.6% ROI and neutral sentiment), highlighting that the path is not guaranteed and carries risk alongside potential upside." ,
Tap a question to reveal the answer.
2030 forecast: min $5.03, avg $7.26, max $11.36; ROI 37%; sentiment BULLISH.
Forecast shows a mixed near term but bullish sentiment from 2029 onward, with 2029 avg $7.14 (ROI 34.8%), 2030 avg $7.26 (ROI 37%), 2040 avg $9.78 (ROI 84.6%), and 2050 avg $20.05 (ROI 278.3%). Note that 2027 shows ROI -3.6% with neutral sentiment.
Yes. The 2030 max is $11.36, and 2031 max is $11.25, with 2033 max $11.39, indicating potential to exceed $11 in some years.
The 30-day range is $4.13 to $6.80; RSI is 40; SMA50 is $6.17; SMA200 is $14.65; support is $4.88 and resistance is $6.15; current price is $5.30.
Market cap is $166.18M and rank is 3877.
LENZ Therapeutics, Inc. Community Discussion
0Share your LENZ Therapeutics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.